Home > Projects

Projects

  1. (CLINIGENE): European Network for the advancement of clinical Gene transfer and therapy (CLINIGENE)

    Dickson, G. & Yáñez-Muñoz, R. J.

    European Union: £8,716, European Union: £165,991, European Union: £13,474, European Union: £60,464, European Commission: £15,044, European Union: £3,874, European Commission: £7,749

    1/06/0630/11/07

    Project: Research

  2. Development of AAV Vectors Encoding Micro-Dystrophin & GDF8 (Myostatin) Propeptide cDNAs for Preclinical DMD Gene Therapy Studies

    Dickson, G.

    Muscular Dystrophy Campaign: £103,720, Muscular Dystrophy Campaign: £98,016

    1/10/0630/09/07

    Project: Research

  3. Optimization and Efficacy of Transcutaneous “Stealth” Adenovirus Vector Vaccine

    Dickson, G.

    Bill and Melinda Gates Foundation: £83,875, Bill and Melinda Gates Foundation: £16,130, Bill and Melinda Gates Foundation: £160,347, Bill and Melinda Gates Foundation: £134,957, Bill and Melinda Gates Foundation: £80,828, Bill and Melinda Gates Foundation: £105,875

    1/09/0631/08/07

    Project: Research

  4. Trojan Horse Vaccines for HIV Based Lentiviral Vectors Expressing Suicide Enveloppes

    Dickson, G.

    Bill and Melinda Gates Foundation: £54,576

    1/10/0830/09/09

    Project: Research

  5. ICE: Towards clinical trials for DMD using gene and cell therapies combined with exon skipping strategies

    Dickson, G.

    Association Monégasque Contre les Myopathies: £58,121

    1/11/0831/10/09

    Project: Research

  6. Second Generation Micro-Dystrophin Gene Therapy for Duchenne Muscular Dystrophy

    Dickson, G.

    Duchenne Ireland: £58,721

    1/04/0930/09/10

    Project: Research

  7. Infinite-Epitope Virus-like-Particle Vaccines for HIV/AIDS

    Dickson, G.

    Bill and Melinda Gates Foundation: £66,729

    1/05/0930/04/10

    Project: Research

  8. OPMD: Translational studies towards physiological and genetic therapy for Oculopharyngeal Muscular Dystrophy (OPMD)

    Dickson, G.

    Association Francais contre les Myopathies: £35,505

    1/10/0930/09/10

    Project: Research

  9. Enhancing the therapeutic functionality of AAV vectors encoding dystrophin for preclinical DMD gene therapy studies

    Dickson, G.

    Muscular Dystrophy Campaign: £63,925, Muscular Dystrophy Campaign: £67,006, Muscular Dystrophy Campaign: £67,006

    1/10/0930/09/10

    Project: Research